Other research analysts have also issued reports about the stock. SVB Leerink lowered their price objective on shares of Clover Health Investments from $3.00 to $1.50 and set a market perform rating on the stock in a research note on Tuesday, November 8th. Citigroup decreased their target price on shares of Clover Health Investments from $3.50 to $1.80 and set a neutral rating on the stock in a research report on Wednesday. Canaccord Genuity Group decreased their target price on shares of Clover Health Investments from $7.00 to $4.00 in a research report on Tuesday, November 8th. Finally, Credit Suisse Group cut their price target on shares of Clover Health Investments from $3.50 to $3.00 and set an underperform rating for the company in a report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of Hold and a consensus price target of $3.01.
Clover Health Investments Trading Up 3.9 %
CLOV opened at $1.33 on Wednesday. The firm’s fifty day simple moving average is $1.70 and its 200 day simple moving average is $2.30. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.05. Clover Health Investments has a 12 month low of $1.22 and a 12 month high of $5.87. The stock has a market capitalization of $635.66 million, a P/E ratio of -1.36 and a beta of 1.95.
Hedge Funds Weigh In On Clover Health Investments
About Clover Health Investments
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses.
- Get a free copy of the StockNews.com research report on Clover Health Investments (CLOV)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Verra Mobility Stock Has Returned Back to the Station
- Does ASML’s November Rally Have Staying Power?
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.